科前生物
(688526)
| 流通市值：71.88亿 | | | 总市值：71.88亿 |
| 流通股本：4.66亿 | | | 总股本：4.66亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 599,927,287.85 | 543,478,592.74 | 398,150,650.98 | 688,952,391.95 |
| 应收票据及应收账款 | 276,542,510.51 | 334,757,347.43 | 334,409,367.7 | 297,759,485.57 |
| 应收账款 | 276,542,510.51 | 334,757,347.43 | 334,409,367.7 | 297,759,485.57 |
| 应收款项融资 | 61,919,559.19 | 20,057,052.92 | 610 | 5,276,435.29 |
| 预付款项 | 5,862,029.47 | 2,856,407.34 | 4,340,687.65 | 3,828,620.39 |
| 其他应收款合计 | 4,702,103.75 | 4,871,442.77 | 4,822,722 | 4,902,108.85 |
| 存货 | 124,008,306.88 | 125,598,204.67 | 110,569,040.67 | 133,639,615.85 |
| 一年内到期的非流动资产 | 769,221,422.17 | 669,192,938.92 | 804,681,617.19 | 753,584,688.82 |
| 其他流动资产 | 32,427,957.38 | 52,758,667.05 | 71,949,048.43 | 38,085,602.46 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,581,193,766.69 | 2,473,078,015.08 | 2,396,570,097.09 | 2,571,347,456.93 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 74,439,621.88 | 59,080,282.3 | 94,020,581.59 | 100,941,818.06 |
| 固定资产 | 711,114,114.92 | 734,739,719.35 | 736,142,700.86 | 755,649,505.04 |
| 在建工程 | 169,541,236.18 | 134,512,448.98 | 107,621,473.96 | 74,703,106.42 |
| 生产性生物资产 | 10,295,876.72 | 10,898,057.86 | 8,701,870.98 | 7,513,017.09 |
| 使用权资产 | 6,542,081.87 | 6,903,672.34 | 6,028,025.81 | 6,332,438.27 |
| 无形资产 | 64,106,199.88 | 65,103,156.95 | 59,567,614.02 | 57,662,071.09 |
| 商誉 | - | - | 3,307,452.36 | 3,307,452.36 |
| 长期待摊费用 | 1,458,483.2 | 1,595,396.66 | 1,212,679.99 | 1,037,503.32 |
| 递延所得税资产 | 1,215,536.87 | 959,239.68 | 189,357.67 | 246,869.57 |
| 其他非流动资产 | 1,019,647,560.45 | 1,008,951,926.86 | 1,018,602,996.42 | 892,114,739.42 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,058,360,711.97 | 2,022,743,900.98 | 2,035,394,753.66 | 1,899,508,520.64 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,639,554,478.66 | 4,495,821,916.06 | 4,431,964,850.75 | 4,470,855,977.57 |
| 流动负债: | | | | |
| 短期借款 | - | - | 57,038,838.8 | 202,132,835.36 |
| 应付票据及应付账款 | 172,008,076.78 | 178,262,032.55 | 135,178,858.53 | 123,551,368.06 |
| 其中：应付票据 | 53,711,375.32 | 32,065,744.7 | 18,505,225.55 | 17,475,562.5 |
| 应付账款 | 118,296,701.46 | 146,196,287.85 | 116,673,632.98 | 106,075,805.56 |
| 合同负债 | 215,009,215.7 | 148,602,632.97 | 179,480,006.86 | 172,483,564.7 |
| 应付职工薪酬 | 27,409,293.53 | 53,904,867.7 | 41,058,984.46 | 30,673,279.39 |
| 应交税费 | 32,406,088.54 | 34,988,431.87 | 29,078,160.5 | 21,231,229.72 |
| 其他应付款合计 | 33,878,386.56 | 45,870,221.59 | 40,744,259.08 | 37,974,051.54 |
| 一年内到期的非流动负债 | 1,375,459.65 | 1,350,777.43 | 1,240,113.35 | 31,210,100.44 |
| 其他流动负债 | 2,703,942.57 | 519,184.89 | 1,460,766.89 | 1,173,975 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 484,790,463.33 | 463,498,149 | 485,279,988.47 | 620,430,404.21 |
| 非流动负债: | | | | |
| 租赁负债 | 5,555,930.74 | 5,545,946.13 | 5,442,532.35 | 5,421,680.86 |
| 递延收益 | 64,070,703.02 | 66,040,575.43 | 67,507,699.7 | 69,380,611.94 |
| 递延所得税负债 | 20,047,205.75 | 17,714,034.54 | 15,062,730.22 | 11,176,905.99 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 89,673,839.51 | 89,300,556.1 | 88,012,962.27 | 85,979,198.79 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 574,464,302.84 | 552,798,705.1 | 573,292,950.74 | 706,409,603 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 466,128,056 | 466,128,056 | 466,128,056 | 466,168,016 |
| 资本公积 | 1,140,131,280.73 | 1,140,131,280.73 | 1,140,131,360.65 | 1,140,618,473.05 |
| 减:库存股 | 35,841,765.86 | 34,766,002.37 | 31,670,006.58 | 30,582,266.52 |
| 其他综合收益 | -1,783,743.34 | -17,140,198.94 | 17,778,531.02 | 29,709,492.24 |
| 盈余公积 | 269,372,446.08 | 269,372,446.08 | 269,372,446.08 | 269,372,446.08 |
| 未分配利润 | 2,225,480,993.98 | 2,117,244,119.5 | 1,995,494,857.19 | 1,887,502,506.32 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,063,487,267.59 | 3,940,969,701 | 3,857,235,244.36 | 3,762,788,667.17 |
| 少数股东权益 | 1,602,908.23 | 2,053,509.96 | 1,436,655.65 | 1,657,707.4 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,065,090,175.82 | 3,943,023,210.96 | 3,858,671,900.01 | 3,764,446,374.57 |
| 负债和股东权益合计 | 4,639,554,478.66 | 4,495,821,916.06 | 4,431,964,850.75 | 4,470,855,977.57 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-31 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |